Gestational Diabetes Global Clinical Trials Review, H1, 2015

Gestational Diabetes Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2678CTIDB
  • |
  • Pages: 67
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Gestational Diabetes Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Gestational Diabetes Global Clinical Trials Review, H1, 2015" provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gestational Diabetes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Gestational Diabetes 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Gestational Diabetes 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Gestational Diabetes Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Novo A/S 32

Clinical Trial Overview of Novo A/S 32

Galenica Ltd. 33

Clinical Trial Overview of Galenica Ltd. 33

F. Hoffmann-La Roche Ltd. 34

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34

Eli Lilly and Company 35

Clinical Trial Overview of Eli Lilly and Company 35

E. Merck KG 36

Clinical Trial Overview of E. Merck KG 36

A. Menarini Industrie Farmaceutiche Riunite Srl 37

Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 37

Clinical Trial Overview of Top Institutes / Government 38

Arak University of Medical Sciences 38

Clinical Trial Overview of Arak University of Medical Sciences 38

Kashan University of Medical Sciences and Health Services 39

Clinical Trial Overview of Kashan University of Medical Sciences and Health Services 39

G. d'Annunzio University 40

Clinical Trial Overview of G. d'Annunzio University 40

VU University Medical Center 41

Clinical Trial Overview of VU University Medical Center 41

Helsinki University Central Hospital 42

Clinical Trial Overview of Helsinki University Central Hospital 42

Kaiser Permanente 43

Clinical Trial Overview of Kaiser Permanente 43

Medical University of Vienna 44

Clinical Trial Overview of Medical University of Vienna 44

National Maternity Hospital 45

Clinical Trial Overview of National Maternity Hospital 45

Oregon Health & Science University 46

Clinical Trial Overview of Oregon Health & Science University 46

Shahid Beheshti University of Medical Sciences 47

Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 47

Five Key Clinical Profiles 48

Appendix 65

Abbreviations 65

Definitions 65

Research Methodology 66

Secondary Research 66

About GlobalData 67

Contact Us 67

Disclaimer 67

Source 67

List of Figures

Gestational Diabetes Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Gestational Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Gestational Diabetes Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Gestational Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Gestational Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Gestational Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 66

List of Tables

Gestational Diabetes Therapeutics, Global, Clinical Trials by Region, 2015* 7

Gestational Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Gestational Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Gestational Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Gestational Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Gestational Diabetes Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Gestational Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Gestational Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Gestational Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Gestational Diabetes Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Gestational Diabetes Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Gestational Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 32

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2015* 33

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 34

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 35

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 36

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2015* 37

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 38

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kashan University of Medical Sciences and Health Services, 2015* 39

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by G. d'Annunzio University, 2015* 40

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2015* 41

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2015* 42

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaiser Permanente, 2015* 43

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 44

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by National Maternity Hospital, 2015* 45

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 46

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novo A/S

Galenica Ltd.

F. Hoffmann-La Roche Ltd.

Eli Lilly and Company

E. Merck KG

A. Menarini Industrie Farmaceutiche Riunite Srl

Gestational Diabetes Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Gestational Diabetes, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160650
Site License
USD 5000 INR 321300
Corporate User License
USD 7500 INR 481950

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com